Yael Kenen
Fortuna: - $ al 30/06/2026
Fortuna: - $ al 30/06/2026
Yael Kenen is currently the Vice President-Clinical Affairs at Epitomee Medical Ltd. Prior to this, Yael worked as the Chief Executive Officer at Lacrima Medical Ltd. and as the Chief Operating Officer at TransPharma Medical Ltd. Yael holds an MBA from Technion-Israel Institute of Technology and a doctorate from The Hebrew University of Jerusalem.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
EPITOMEE MEDICAL LTD -.--% | 12/05/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| EPITOMEE MEDICAL LTD | Director Técnico/Científico/I+D | 01/01/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
Lacrima Medical Ltd.
Lacrima Medical Ltd. Medical SpecialtiesHealth Technology Develops medical treatment device for dry eye disease | Director Ejecutivo | - |
TransPharma Medical Ltd.
TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Provides development and commercialization of drugs | Director de Operaciones | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Technion-Israel Institute of Technology
Technion-Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransPharma Medical Ltd.
TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Provides development and commercialization of drugs | Health Technology |
Epitomee Medical Ltd.
Epitomee Medical Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures medical devices for obesity | Health Technology |
Lacrima Medical Ltd.
Lacrima Medical Ltd. Medical SpecialtiesHealth Technology Develops medical treatment device for dry eye disease | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.